Seroatlas · Human Serome Atlas

ASS1

Argininosuccinate synthase

Also known as: ASS, ASSY_HUMAN, CTLN1

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P00966
Gene
ASS1
Ensembl
ENSG00000130707
Chromosome
9
Canonical length
412 aa
Protein class
Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
Subcellular location
Nucleoplasm,Cytosol
Quaternary structure
Homotetramer

OverviewNCBI Gene

The protein encoded by this gene catalyzes the penultimate step of the arginine biosynthetic pathway. There are approximately 10 to 14 copies of this gene including the pseudogenes scattered across the human genome, among which the one located on chromosome 9 appears to be the only functional gene for argininosuccinate synthetase. Mutations in the chromosome 9 copy of this gene cause citrullinemia. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Aug 2012]

Canonical amino-acid sequenceUniProt

412 residues, UniProt reviewed canonical sequence.

>P00966|ASS1
     1  MSSKGSVVLA YSGGLDTSCI LVWLKEQGYD VIAYLANIGQ KEDFEEARKK ALKLGAKKVF
    61  IEDVSREFVE EFIWPAIQSS ALYEDRYLLG TSLARPCIAR KQVEIAQREG AKYVSHGATG
   121  KGNDQVRFEL SCYSLAPQIK VIAPWRMPEF YNRFKGRNDL MEYAKQHGIP IPVTPKNPWS
   181  MDENLMHISY EAGILENPKN QAPPGLYTKT QDPAKAPNTP DILEIEFKKG VPVKVTNVKD
   241  GTTHQTSLEL FMYLNEVAGK HGVGRIDIVE NRFIGMKSRG IYETPAGTIL YHAHLDIEAF
   301  TMDREVRKIK QGLGLKFAEL VYTGFWHSPE CEFVRHCIAK SQERVEGKVQ VSVLKGQVYI
   361  LGRESPLSLY NEELVSMNVQ GDYEPTDATG FININSLRLK EYHRLQSKVT AK

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against ASS1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.26
Highest tissue expression
1,907 nTPM

Expression across tissuesHPA

Tissue

  • liver: 1,907 nTPM
  • kidney: 1,201 nTPM
  • urinary bladder: 270 nTPM
  • adipose tissue: 210 nTPM
  • small intestine: 184 nTPM
  • breast: 170 nTPM

Single-cell type

  • hepatocytes: 1,157 nCPM
  • enterocytes: 618 nCPM
  • proximal tubule cells: 453 nCPM
  • urothelial cells: 408 nCPM
  • prostatic hillock cells: 399 nCPM
  • prostatic club cells: 337 nCPM

Immune cell

  • plasmacytoid DC: 1.5 nTPM
  • myeloid DC: 0.1 nTPM
  • basophil: 0 nTPM
  • classical monocyte: 0 nTPM
  • eosinophil: 0 nTPM
  • gdT-cell: 0 nTPM

Brain region

  • choroid plexus: 105 nTPM
  • pons: 85 nTPM
  • midbrain: 65 nTPM
  • medulla oblongata: 60 nTPM
  • hypothalamus: 56 nTPM
  • cerebral cortex: 40 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about ASS1.

Disease | AllUniProt

Conditions ASS1 is implicated in, by any mechanism.

Disease | GeneticClinVar

230 pathogenic / likely-pathogenic of 945 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.98
gnomAD pLI
0
gnomAD missense Z
0.76
DepMap mean gene effect
-0.22
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

  • Rossmann-like alpha/beta/alpha sandwich fold
  • Argininosuccinate synthase
  • Argininosuccinate synthase, conserved site
  • Argininosuccinate synthase, type 1 subfamily
  • Argininosuccinate synthetase, catalytic/multimerisation domain body
  • Arginosuccinate synthase-like, N-terminal domain
  • Arginosuccinate synthase C-terminal domain
  • Arginosuccinate synthase N-terminal HUP domain
  • Arginosuccinate synthase C-terminal domain

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of ASS1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads ASS1 as an antibody target. Whether an autoantibody or antibody against ASS1 could matter depends on whether native ASS1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

ASS1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label ASS1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/ASS1. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...